HBM Healthcare Investments AG

Equities

HBMN

CH0012627250

Investment Management & Fund Operators

Market Closed - Swiss Exchange Other stock markets 11:30:38 2024-04-18 am EDT			5-day change	1st Jan Change
185.2 ^CHF	-0.43%		-2.42%	+1.42%

Apr. 03	HBM Healthcare Investments Warns of CHF1 Million Loss for FY24	MT
Jan. 22	HBM Healthcare Investments AG Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

HBM Healthcare Investments Media Release

June 26, 2019 at 12:20 am EDT

Media Release

Zug, 26 June 2019

HBM Healthcare Investments launches new share buy-back programme

At the Annual General Meeting of HBM Healthcare Investments AG on 24 June 2019, the shareholders approved a new share buy-back programme for a maximum of 696'000 shares (10% of the shares issued) for the purpose of cancellation by means of a capital reduction. The repurchase programme will be conducted via a separate trading line on the SIX Swiss Exchange. It begins on Friday, 28 June 2019 and lasts until 27 June 2022 at the latest.

Further information on the new buyback programme can be found on the website at https://www.hbmhealthcare.com/en/investors/information

Contact

For further information, please contact Dr Andreas Wicki on +41 41 710 75 77, or at andreas.wicki@hbmhealthcare.com

HBM Healthcare Investments launches new share buy-back programme (PDF)

Provider		Channel		Contact
Tensid EQS Ltd., Switzerland www.tensid.ch		newsbox.ch www.newsbox.ch		Provider/Channel related enquiries cs@tensideqs.ch +41 41 763 00 50

Latest news about HBM Healthcare Investments AG

HBM Healthcare Investments Warns of CHF1 Million Loss for FY24	Apr. 03	MT
HBM Healthcare Investments AG Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 22	CI
HBM Healthcare Investments Logs Lower Fiscal Q3 Loss	Jan. 22	MT
HBM Healthcare Investments Warns of FY24 Nine-month Net Loss	Jan. 04	MT
AbbVie to Buy Cancer-focused ImmunoGen for $10.1 Billion	Nov. 30	MT
Kepler Cheuvreux Lowers Price Target on HBM Healthcare Investments, Maintains Buy Recommendation	Nov. 21	MT
HBM Healthcare Investments Launches Share Buyback	23-10-16	MT
HBM Healthcare Investments AG Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-16	CI
HBM Healthcare Investments Logs Higher Fiscal H1 Loss	23-10-16	MT
Tranche Update on HBM Healthcare Investments AG's Equity Buyback Plan announced on July 5, 2023.	23-10-16	CI
HBM Healthcare Investments Flags Fiscal H1 Loss	23-10-03	MT
HBM Healthcare Investments AG Reports Earnings Results for the First Quarter Ended June 30, 2023	23-07-21	CI
HBM Healthcare Investments' Ficsal Q1 NAV Per Share Declines	23-07-21	MT
HBM Healthcare Investments AG commences an Equity Buyback Plan under the authorization approved on June 10, 2022.	23-07-05	CI
HBM Healthcare's Portfolio Company Cathay Biotech to Sell Shares for CNY6.6 Billion	23-06-26	MT
Kepler Cheuvreux Lowers Price Target on HBM Healthcare Investments, Maintains Buy Recommendation	23-06-14	MT
HBM Healthcare Investments AG Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-26	CI
HBM Healthcare Investments' Loss Widens in FY23	23-05-12	MT
HBM Healthcare Investments Posts 3% Drop in April NAV	23-05-02	MT
HBM Healthcare Invests $12 Million into US-based ArriVent Biopharma	23-03-28	MT
HBM Healthcare Investments CEO Set to Resume Duties After Health Issues	23-03-28	MT
HBM Healthcare Investments' Portfolio Company Mineralys Therapeutics Completes $192 Million IPO	23-02-13	MT
HBM Healthcare Investments CEO Takes Temporary Leave of Absence	23-01-30	MT
HBM Healthcare Investments AG Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-01-20	CI
HBM Healthcare Swings To Loss In Fiscal Q3 On Negative Currency Effects	23-01-20	MT

Chart HBM Healthcare Investments AG

Duration

Period

More charts

Company Profile

HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.

Sector

Investment Management & Fund Operators

Calendar

2024-05-07 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for HBM Healthcare Investments AG

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

186 CHF

Average target price

236 CHF

Spread / Average Target

+26.88%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Venture Capital

	1st Jan change	Capi.
HBM HEALTHCARE INVESTMENTS AG	+1.42%	1.41B
UMBRA COMPANIES INC.	+31.41%	12.02B
HERCULES CAPITAL, INC.	+9.27%	2.91B
OCTOPUS TITAN VCT PLC	-8.46%	1.22B
CION INVESTMENT CORPORATION	-2.48%	594M
VERUSA HOLDING	+46.95%	567M
MOLTEN VENTURES PLC	-20.39%	511M
WOORI TECHNOLOGY INVESTMENT CO., LTD	+35.40%	495M
OCTOPUS APOLLO VCT PLC	-4.17%	492M
BRITISH SMALLER COMPANIES VCT PLC	+3.90%	304M

Venture Capital